Regulus Therapeutics Inc (RGLS)
2.205
-0.02
(-1.12%)
USD |
NASDAQ |
May 10, 16:00
2.205
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Shareholders Equity (Quarterly): 21.19M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.19M |
September 30, 2023 | 28.26M |
June 30, 2023 | 34.00M |
March 31, 2023 | 26.60M |
December 31, 2022 | 33.29M |
September 30, 2022 | 39.67M |
June 30, 2022 | 42.37M |
March 31, 2022 | 49.24M |
December 31, 2021 | 54.96M |
September 30, 2021 | 29.01M |
June 30, 2021 | 36.83M |
March 31, 2021 | 27.11M |
December 31, 2020 | 26.03M |
September 30, 2020 | 7.754M |
June 30, 2020 | 8.584M |
March 31, 2020 | 14.90M |
December 31, 2019 | 20.02M |
September 30, 2019 | -0.143M |
June 30, 2019 | 4.743M |
March 31, 2019 | -6.069M |
December 31, 2018 | -5.854M |
September 30, 2018 | 1.578M |
June 30, 2018 | 10.43M |
March 31, 2018 | 22.88M |
Date | Value |
---|---|
December 31, 2017 | 35.22M |
September 30, 2017 | 48.58M |
June 30, 2017 | 20.00M |
March 31, 2017 | 38.73M |
December 31, 2016 | 56.08M |
September 30, 2016 | 72.68M |
June 30, 2016 | 88.45M |
March 31, 2016 | 107.23M |
December 31, 2015 | 124.08M |
September 30, 2015 | 125.86M |
June 30, 2015 | 132.63M |
March 31, 2015 | 146.82M |
December 31, 2014 | 132.01M |
September 30, 2014 | 74.08M |
June 30, 2014 | 82.08M |
March 31, 2014 | 92.29M |
December 31, 2013 | 93.46M |
September 30, 2013 | 94.45M |
June 30, 2013 | 49.32M |
March 31, 2013 | 55.87M |
December 31, 2012 | 62.09M |
September 30, 2012 | -51.15M |
June 30, 2012 | 2.484M |
December 31, 2011 | -41.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.143M
Minimum
Sep 2019
54.96M
Maximum
Dec 2021
26.55M
Average
27.11M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 464.04M |
ADMA Biologics Inc | 135.21M |
FibroGen Inc | -228.12M |
Protara Therapeutics Inc | 58.41M |
Amylyx Pharmaceuticals Inc | 433.43M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 30.75M |
Total Liabilities (Quarterly) | 9.563M |